XML 39 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2012
Summary of Derivative Instruments [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
The following table summarizes the fair value of derivative instruments recorded in the consolidated balance sheets as of September 30, 2012 and December 31, 2011 (dollars in thousands):
 
September 30, 2012
 
December 31, 2011
Liability Derivatives:
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
Derivatives designated as hedges:
 
 
 
 
 
 
 
Interest rate swap agreement
Accrued expenses
 
$
4,429

 
Accrued expenses
 
$
4,143

Interest rate swap agreement
Other long-term liabilities
 

 
Other long-term liabilities
 
2,882

Total derivatives designated as hedges
 
 
$
4,429

 
 
 
$
7,025

Derivatives not designated as hedges:
 
 
 
 
 
 
 
Cross-currency swap agreement
Accrued expenses
 
$
8,709

 
Accrued expenses
 
$
7,170

Contingent forward sale contract
Other long-term liabilities
 
50,106

 
Other long-term liabilities
 

Total liability derivatives not designated as hedges
 
 
$
58,815

 
 
 
$
7,170

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]
The following table shows the effect of the Company’s derivative instrument designated as a cash flow hedge for the three and nine months ended September 30, 2012 and 2011 in other comprehensive income/(loss) (OCI) (dollars in thousands): 
 
Total Cash Flow Hedge OCI Activity, Net of Tax
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
Derivatives Designated as Cash Flow Hedges:
2012
 
2011
 
2012
 
2011
Effective portion of changes in fair value recognized in OCI:
 
 
 
 
 
 
 
Interest rate swap agreement
$
592

 
$
187

 
$
1,655

 
$
632

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]
The following table shows the effect of the Company’s derivative instruments not designated as hedges for the three and nine months ended September 30, 2012 and 2011 in the consolidated statement of operations (dollars in thousands): 
 
 
 
 
Amount Recognized in Earnings
Derivative Instruments Not Designated as Hedges:
 
 
 
Three Months Ended
 
Nine Months Ended
 
Location of Amount Recognized in Earnings
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
Cross-currency swap agreement
 
Interest expense, net
 
$
(1,051
)
 
$
(1,566
)
 
$
(3,572
)
 
$
(4,526
)
Cross-currency swap agreement
 
Other income, net
 
(70
)
 
103

 
218

 
222

Contingent forward sale contract
 
Contingent forward sale contract mark-to-market expense
 
(50,106
)
 

 
(50,106
)
 

 
 
 
 
$
(51,227
)
 
$
(1,463
)
 
$
(53,460
)
 
$
(4,304
)